906
Views
28
CrossRef citations to date
0
Altmetric
Review

Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease

, MD, , MD, , MD PhD, , MD PhD, , MD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Chi Chiu Mok. (2019) Metabolic syndrome and systemic lupus erythematosus: the connection. Expert Review of Clinical Immunology 15:7, pages 765-775.
Read now
Ray O. Bahado-Singh, Argyro Syngelaki, Rupsari Mandal, Stewart F. Graham, Ranjit Akolekar, Beomsoo Han, Trent C. Bjondahl, Edison Dong, Samuel Bauer, Zeynep Alpay-Savasan, Onur Turkoglu, Dotun Ogunyemi, Liona C. Poon, David S. Wishart & Kypros H. Nicolaides. (2017) Metabolomic determination of pathogenesis of late-onset preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 30:6, pages 658-664.
Read now
Justin Tawil & Theresa A Gelzinis. (2016) Differential diagnosis and clinical management of diastolic heart failure: current best practice. Research Reports in Clinical Cardiology 7, pages 117-135.
Read now

Articles from other publishers (25)

Mawieh Hamad, Jibran Sualeh Muhammad, Bilal Rah, Haydar Hasan, Jalal Taneera, Abdulsalam Soofi & Samir Awadallah. (2023) PCSK9 Inhibitors as Adjunctive Therapies in Hypercholesterolemia: Benefits, Limitations, and Possible Alternatives. Advanced Therapeutics.
Crossref
Natasha de Alwis, Natalie K. Binder, Yeukai T.M. Mangwiro, Natasha Pritchard, Sally Beard, Tu’uhevaha J. Kaitu’u-Lino, Fiona Brownfoot & Natalie J. Hannan. (2022) The effect of metformin on cardiovascular markers in female mice consuming a high fat diet. Obesity Research & Clinical Practice 16:6, pages 524-532.
Crossref
Khim Boon Tee, Luqman Ibrahim, Najihah Mohd Hashim, Mohd Zuwairi Saiman, Zaril Harza Zakaria & Hasniza Zaman Huri. (2022) Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes. Pharmaceutics 14:6, pages 1268.
Crossref
Amjad Ali, Hema Unnikannan, Jasmin Shafarin, Khuloud Bajbouj, Jalal Taneera, Jibran Sualeh Muhammad, Haydar Hasan, Albert Salehi, Samir Awadallah & Mawieh Hamad. (2022) Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells. Endocrine 76:3, pages 543-557.
Crossref
Jiao Lu, Jingjing Liu, Liumei Zhang, Xueqi Wang, Yuan Zhang & Qiang Tang. (2021) Morphological and functional characterization of diabetic cardiomyopathy in db/db mice following exercise, metformin alone, or combination treatments. Biochemical and Biophysical Research Communications 584, pages 80-86.
Crossref
Ji Yeon Han & Sochung Chung. (2021) Evaluation of Agreement of Overweight Screening Criteria in Adolescents: Korean National Health and Nutrition Examination Surveys. Journal of Obesity & Metabolic Syndrome 30:3, pages 289-295.
Crossref
Roger K. W. Smith & C. Wayne McIlwraith. (2021) “One Health” in tendinopathy research: Current concepts. Journal of Orthopaedic Research 39:8, pages 1596-1602.
Crossref
Nahid Alimoradi, Negar Firouzabadi & Reihaneh Fatehi. (2021) Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs. Biomedicine & Pharmacotherapy 139, pages 111662.
Crossref
Ricardo Ladeiras-Lopes, Francisco Sampaio, Sara Leite, Diogo Santos-Ferreira, Eduardo Vilela, Adelino Leite-Moreira, Nuno Bettencourt, Vasco Gama, Pedro Braga & Ricardo Fontes-Carvalho. (2021) Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial. Endocrine 72:3, pages 699-710.
Crossref
Lanman Xu, Xiaofang Wang, Yan Chen, Lynn Soong, Yongping Chen, Jiyang Cai, Yuejin Liang & Jiaren Sun. (2021) Metformin Modulates T Cell Function and Alleviates Liver Injury Through Bioenergetic Regulation in Viral Hepatitis. Frontiers in Immunology 12.
Crossref
Harsha Jain, Aditi Rajan Bhat, Harshita Dalvi, Chandraiah Godugu, Shashi Bala Singh & Saurabh Srivastava. (2021) Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment. Current Research in Pharmacology and Drug Discovery 2, pages 100041.
Crossref
Koh Ono, Hiromichi Wada, Noriko Satoh-Asahara, Hitoki Inoue, Keita Uehara, Junichi Funada, Atsushi Ogo, Takahiro Horie, Masatoshi Fujita, Akira Shimatsu & Koji Hasegawa. (2019) Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial. American Journal of Cardiovascular Drugs 20:3, pages 283-293.
Crossref
Alireza SadeghiSeyed Mohammad MousaviTahereh MokhtariMohammad ParohanAlireza Milajerdi. (2020) Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Childhood Obesity 16:3, pages 174-191.
Crossref
Warda Meziane, Zineb Mekkaoui, Ismahane Hai, Kamila Kacimi, Khuira Djilali, Chafia Touil-Boukoffa, Gérard Lefranc, Anne Fernandez, Ned Lamb, Franck Mennechet & Mourad Aribi. (2019) Combination of metformin with sodium selenite induces a functional phenotypic switch of human GM-CSF monocyte-derived macrophages. International Immunopharmacology 73, pages 212-224.
Crossref
Vicente Corrêa Júnior, Flávio Danni Fuchs, Beatriz D. Schaan, Leila Beltrami Moreira, Sandra Costa Fuchs & Miguel Gus. (2018) Effect of metformin on blood pressure in patients with hypertension: a randomized clinical trial. Endocrine 63:2, pages 252-258.
Crossref
Aleksandr B. Shek, Rano B. Alieva, Ravshanbek D. Kurbanov, Shavkat U. Hoshimov, Ulugbek I. Nizamov & Adolat V. Ziyaeva. (2019) Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?. Archives of Medical Science – Atherosclerotic Diseases 4:1, pages 144-150.
Crossref
Nicholas J. Hunt, Peter A.G. McCourt, David G. Le Couteur & Victoria C. Cogger. (2018) Novel targets for delaying aging: The importance of the liver and advances in drug delivery. Advanced Drug Delivery Reviews 135, pages 39-49.
Crossref
Gabriela Medina, Olga Vera-Lastra, Ana Lilia Peralta-Amaro, María Pilar Jiménez-Arellano, Miguel Angel Saavedra, María Pilar Cruz-Domínguez & Luis J. Jara. (2018) Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacological Research 133, pages 277-288.
Crossref
Sen Xu, Zongyuan Yang, Ping Jin, Xin Yang, Xiaoting Li, Xiao Wei, Ya Wang, Sixiang Long, Taoran Zhang, Gang Chen, Chaoyang Sun, Ding Ma & Qinglei Gao. (2018) Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer. Molecular Cancer Therapeutics 17:6, pages 1291-1302.
Crossref
Ruifei Chen, Yenan Feng, Jimin Wu, Yao Song, Hao Li, Qiang Shen, Dan Li, Jianshu Zhang, Zhizhen Lu, Han Xiao & Youyi Zhang. (2018) Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α. British Journal of Pharmacology 175:8, pages 1217-1229.
Crossref
Magdalena Markowicz-Piasecka, Joanna Sikora, Aleksandra Szydłowska, Agata Skupień, Elżbieta Mikiciuk-Olasik & Kristiina M. Huttunen. (2017) Metformin – a Future Therapy for Neurodegenerative Diseases. Pharmaceutical Research 34:12, pages 2614-2627.
Crossref
Yu-Guang Ma, Liang Liang, Yin-Bin Zhang, Bao-Feng Wang, Yun-Gang Bai, Zhi-Jun Dai, Man-Jiang Xie & Zhong-Wei Wang. (2017) Berberine reduced blood pressure and improved vasodilation in diabetic rats. Journal of Molecular Endocrinology 59:3, pages 191-204.
Crossref
Ming-Min Chung, Christopher J. Nicol, Yi-Chuan Cheng, Kuan-Hung Lin, Yen-Lin Chen, Dee Pei, Chien-Hung Lin, Yi-Nuo Shih, Chia-Hui Yen, Shiang-Jiuun Chen, Rong-Nan Huang & Ming-Chang Chiang. (2017) Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. Experimental Cell Research 352:1, pages 75-83.
Crossref
Marleen M. J. van Greevenbroek, Casper G. Schalkwijk & Coen D.A. Stehouwer. (2016) Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances. F1000Research 5, pages 2515.
Crossref
Emilia D'Elia, Muthiah Vaduganathan, Mauro Gori, Antonello Gavazzi, Javed Butler & Michele Senni. (2015) Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use. European Journal of Heart Failure 17:12, pages 1231-1239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.